Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.

Autor: Othman J; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Hwang A; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom., Brodermann M; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom., Abdallah I; Department of Haematology, Leeds Teaching Hospitals Trust, Leeds, United Kingdom., McCloskey K; Haematology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Gallipoli P; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Clarke G; Clinical Haematology, James Cook University Hospital, Middlesbrough, United Kingdom., Dang R; Clinical Haematology, James Cook University Hospital, Middlesbrough, United Kingdom., Vidler J; Haematology, King's College Hospital, London, United Kingdom., Krishnamurthy P; Haematology, King's College Hospital, London, United Kingdom., Basheer F; Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom., Latif AL; Department of Haematology, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Palanicawandar R; Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom., Taylor T; Department of Haematology, Nottingham University Hospital, Nottingham, United Kingdom., Khan A; Department of Clinical Haematology, Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom., Campbell V; Haematology Centre, Western General Hospital, Edinburgh, United Kingdom., Hogan F; Haematology Department, University Hospital of Wales, Cardiff, United Kingdom., Kanellopoulos A; Clinical Haematology, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Fleming K; Bristol Haematology and Oncology Centre, University Hospital Bristol and Weston, Bristol, United Kingdom., Collins A; Haematology Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom., Dalley C; Haematology Department, University Hospital Southampton, Southampton, United Kingdom., Loke J; Centre for Clinical Haematology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Marshall S; Haematology, City Hospitals Sunderland NHS Trust, Sunderland, United Kingdom., Taussig D; Haemato-oncology Unit, Royal Marsden Hospital, The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom., Munisamy S; Haematology Department, East Kent Hospitals University NHS Foundation, Canterbury, United Kingdom., Loizou E; Haematology, Mersey and West Lancashire Teaching Hospitals NHS Trust, Whiston, United Kingdom., Yassin H; Haematology, University Hospitals Sussex NHS Foundation Trust, Worthing, United Kingdom., Dennis M; Haematology and Transplant Unit, The Christie NHS Foundation Trust, Manchester, United Kingdom., Zhao R; Haematology, Torbay Hospital, Torquay, United Kingdom., Belsham E; Haematology, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom., Murray D; Haematology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom., Fowler N; Haematology, Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom., O'Nions J; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom., Khan A; Department of Haematology, Leeds Teaching Hospitals Trust, Leeds, United Kingdom., Sellar R; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; Department of Haematology, UCL Cancer Institute, London, United Kingdom., Dillon R; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Publikováno v: Blood advances [Blood Adv] 2024 Nov 12; Vol. 8 (21), pp. 5590-5597.

Three-Dimensionally Printed Simulated Tracheas to Improve Cricothyrotomy Skills Among Anesthesia Providers.

Autor: Hogan F; is a staff CRNA at the University of Louisville Hospital, Louisville, Kentucky. Email: felicia.hogan@fulbrightmail.org., O'Dell C; is the Regional Technical Coordinator with Bewegen Technologies Inc., Raleigh, North Carolina., Pearson J; is the Manager of PeriAnesthesia Services at CarolinaEast, New Bern, North Carolina; she is also adjunct faculty at Texas Christian University., Parrish J; is a staff CRNA at CarolinaEast in New Bern, North Carolina., Simmons VC; is an Associate Professor and the Director of the Duke University Nurse Anesthesia Program.

Publikováno v: AANA journal [AANA J] 2023 Feb; Vol. 91 (1), pp. 23-30.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phylogenetic and geographical analysis of a retrovirus during the early stages of endogenous adaptation and exogenous spread in a new host.

Autor: Quigley BL; Genecology Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia., Wedrowicz F; School of Science, Psychology and Sport, Federation University Australia, Churchill, Vic., Australia., Hogan F; School of Science, Psychology and Sport, Federation University Australia, Churchill, Vic., Australia., Timms P; Genecology Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia.

Publikováno v: Molecular ecology [Mol Ecol] 2021 Jun; Vol. 30 (11), pp. 2626-2640. Date of Electronic Publication: 2020 Dec 30.

Marine Cyanobacteria: A Rich Source of Structurally Unique Anti-Infectives for Drug Development.

Autor: Tan, Lik Tong¹ (AUTHOR) liktong.tan@nie.edu.sg, Salleh, Nurul Farhana¹ (AUTHOR)

Publikováno v: Molecules. Nov2024, Vol. 29 Issue 22, p5307. 60p.